Seer Reports Third Quarter 2022 Financial Results
November 08, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022
October 13, 2022 16:15 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
Seer to Participate in the Morgan Stanley Global Healthcare Conference
August 30, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
Seer Announces Publication of Seminal Study Demonstrating the Power of Engineered Nano-Bio Interactions to Enable Deep Access to the Proteome
August 23, 2022 08:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) today announced the publication of a study demonstrating the performance of the technology underlying the...
Seer Reports Second Quarter 2022 Financial Results
August 09, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph™ Analysis Suite 2.0
August 03, 2022 09:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced a new...
Seer to Report Second Quarter 2022 Financial Results on August 9, 2022
July 14, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
Seer Reports First Quarter 2022 Financial Results
May 04, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer to Present at the BofA Securities 2022 Healthcare Conference
April 28, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
Seer to Report First Quarter Financial Results on May 4, 2022
April 07, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...